Clinical Trial Update: Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating contrast-enhanced ultrasound for subtyping and staging of kidney cancer; study completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-11-13